Clinical aspects of iron use in the anemia of kidney disease.
about
Oral iron for people with chronic kidney diseaseIatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st CenturyThe importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected dataReduction of costs for anemia-management drugs associated with the use of ferric citrateIron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD.Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients.Iron supplementation and mortality in incident dialysis patients: an observational study.Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial.Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study.Effect of Intravenous Iron Supplementation on Acute Mountain Sickness: A Preliminary Randomized Controlled Study.Vitamin C and functional iron deficiency anemia in hemodialysisEffect of Intravenous Iron Supplementation on Iron Stores in Non-Anemic Iron-Deficient Patients with Hereditary Hemorrhagic Telangiectasia.Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patientsIron Status of Cats with Chronic Kidney Disease.Internal medicine, renal anaemia, and erythropoiesis-stimulating agents (ESAS).Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patientsSafety issues with intravenous iron products in the management of anemia in chronic kidney diseasePredictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patientsAt pharmacologically relevant concentrations intravenous iron preparations cause pancreatic beta cell death.Signal-intensity-ratio MRI accurately estimates hepatic iron load in hemodialysis patients.Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation ModelShould we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?Anaemia management and mortality risk in chronic kidney disease.Iron deficiency anaemia in chronic kidney disease.Rare cause of weight loss in a kidney transplant recipient: iron overload.Hepatic Iron Load at Magnetic Resonance Imaging Is Normal in Most Patients Receiving Peritoneal Dialysis.Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease.Relationships between iron dose, hospitalizations and mortality in incident haemodialysis patients: a propensity-score matched approach.Use of Erythropoietin-Stimulating Agents (ESA) in Patients With End-Stage Renal Failure Decided to Forego Dialysis: Palliative Perspective.Iron supplementation associates with low mortality in pre-dialyzed advanced chronic kidney disease patients receiving erythropoiesis-stimulating agents: a nationwide database analysis.Stable and high-yielding intrinsic (59) Fe-radiolabeling of the intravenous iron preparations Monofer and Cosmofer.Iron isotopic composition of blood serum in anemia of chronic kidney disease.Anemia in elderly hospitalized patients: prevalence and clinical impact.[Iron deficiency : Recognition and treatment].Elevated Neutrophil Gelatinase Lipocalin Levels Are Associated With Increased Oxidative Stress in Hemodialysis Patients.Association of Anemia and Iron Parameters With Mortality Among Patients Undergoing Prevalent Hemodialysis in Taiwan: The AIM - HD StudySwitching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
P2860
Q24187625-09EE969F-4BB5-4E78-ABC3-99D505CCFECEQ26752664-9A712BE0-CA8D-47BA-A805-701B2181D458Q33412890-DABA1736-6B2E-431B-BAB0-FD1435D10FDDQ33685424-0383C024-EA85-473B-8CE4-D43CA18EAD03Q34427619-5582DB04-82D7-4C59-906F-2310D75E11CCQ34506972-A15A20EE-A690-4AA5-89EF-EA0645CE4AA8Q34612274-960F7019-159E-4D40-B7B4-709A30B5634DQ34628344-C1C70088-A384-4C43-8B29-1D7DF72E68F0Q34884492-53D7F035-75C2-4983-BA5C-9DD92074F39BQ35891670-07D39C4F-62F1-46D0-9E7E-0A1531A1D475Q36468512-0C857F9E-F9F8-4806-9AF3-9217ECAF195EQ36751222-A214E24E-89B8-440D-BFBD-0BD99D442EB4Q36842398-357A8264-3890-4D68-8DAA-7D1F2AA995DAQ36975638-51563E59-ADD1-4F81-8191-8A71F9E501A5Q37113720-6CEA6A99-D0C2-4799-9B1C-C6E16DD3FC3EQ37123216-994C1A3F-FEE5-4B68-986A-29456B7994D1Q37161960-6152727C-011B-4F00-9916-1AE863017F80Q37214510-31E5217B-B641-45D0-A0A4-8DD17089C550Q37369071-F094A3AA-C28E-4649-B38D-A250C070920AQ37570855-109EC66D-0F7A-4B17-BCBB-68415C4A3E58Q37653426-EA675E75-EF40-4728-A26E-B25A5C7B3B02Q38051056-1C62C63A-46CF-4ACC-8761-6F75C5FA4D91Q38084470-4B1FCDC0-9D03-4CD4-B217-48F28E9F916DQ38126230-74DB2006-7641-49F6-9D02-840C17935468Q42267597-51A5024D-48E5-4B43-8F0C-621AFF6C1B57Q47102467-AE13CA92-FA97-4063-8130-CDEA81BC2B39Q47129994-6FFDCC21-6C14-46E5-BA0D-0132DF3969C8Q47835950-BDF163D1-819B-401E-9861-E0E804D191AFQ47868514-92E21908-59CA-4C9A-9950-D4FA6B45263EQ48086832-7390B9BA-6EF9-4C14-93DD-32813D19DBD3Q48197122-9FF0FD24-F4D5-46F0-BF3D-C418DF666DD6Q49103122-EADB509C-96ED-49C8-9312-6CDAAE96A35EQ50966542-05FB8480-3D94-4C9E-A224-DB36E83FE811Q52838800-1C97A986-ADA1-4231-9BAF-1897C4EA02F1Q55162344-39DD7BD6-B224-45D8-80AF-BDA5C12E3671Q58130103-7200E011-AFBF-4679-961E-97BF259AEE61Q58711479-E1B330A8-C71C-4F54-B241-3B88274CC5B4
P2860
Clinical aspects of iron use in the anemia of kidney disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Clinical aspects of iron use in the anemia of kidney disease.
@ast
Clinical aspects of iron use in the anemia of kidney disease.
@en
type
label
Clinical aspects of iron use in the anemia of kidney disease.
@ast
Clinical aspects of iron use in the anemia of kidney disease.
@en
prefLabel
Clinical aspects of iron use in the anemia of kidney disease.
@ast
Clinical aspects of iron use in the anemia of kidney disease.
@en
P356
P1476
Clinical aspects of iron use in the anemia of kidney disease.
@en
P2093
Walter H Hörl
P304
P356
10.1681/ASN.2006080856
P577
2007-01-17T00:00:00Z